ATLAS / Macro Radar / Reporting / MLYS

Mineralys Therapeutics, Inc. (MLYS) reporting calendar

Mineralys Therapeutics, Inc. files periodic reports with the SEC as MLYS on Nasdaq. Atlas tracks 14 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 29 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
14

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MLYS market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001933414-26-000084
10-K31 Dec 202512 Mar 202671 days0001933414-26-000056
10-Q30 Sep 202510 Nov 202541 days0001933414-25-000142
10-Q30 Jun 202512 Aug 202543 days0001933414-25-000090
10-Q31 Mar 202512 May 202542 days0001933414-25-000058
10-K31 Dec 202412 Feb 202543 days0001933414-25-000009
10-Q30 Sep 202412 Nov 202443 days0001933414-24-000057
10-Q30 Jun 202413 Aug 202444 days0001933414-24-000039
10-Q31 Mar 20249 May 202439 days0001933414-24-000016
10-K31 Dec 202321 Mar 202481 days0001628280-24-012358
10-Q30 Sep 20237 Nov 202338 days0001933414-23-000087
10-Q30 Jun 20237 Aug 202338 days0001933414-23-000056
10-Q31 Mar 202315 May 202345 days0001933414-23-000038
10-K31 Dec 202215 Mar 202374 days0001933414-23-000012

Source: SEC EDGAR company submissions for CIK 0001933414. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.